Innovator ETFs Announces New Upside Caps for May Series of S&P 500 Buffer ETFs


All 36 S&P 500 Buffer ETFs from Innovator have successfully rebalanced and reset at least once


Defined Outcome ETFs seek to provide S&P 500 exposure up to a cap, with downside buffer levels of 9%, 15% or 30% over one-year Outcome Period

CHICAGO, May 03, 2021 (GLOBE NEWSWIRE) — Innovator Capital Management, LLC (Innovator) today announced the upside caps and return profiles for the May series of the S&P 500 Buffer ETFs™ – Innovator S&P 500 Buffer ETF™ – May (BMAY), Innovator S&P 500 Power Buffer ETF™ – May (PMAY) and Innovator S&P 500 Ultra Buffer ETF™ – May (UMAY) – which completed their first outcome period and reset at the end of the month. The May ETFs were the final series of the S&P 500 Buffer ETF™ suite to list in 2020, completing monthly issuance of Innovator’s flagship Defined Outcome ETF™ lineup.

The 36 total ETFs, which now have all successfully rebalanced at least once, provide investors with upside participation, to a cap, in Large-cap U.S. stocks via options on the S&P 500 with buffers against market losses of 9%, 15% or 30% over one year periods. The return profiles for the three ETFs in the May S&P 500 Buffer ETF™ series will span the year from today to April 30th, 2022.

Return profiles for the Innovator S&P 500 Buffer ETFs

– May Series, as of 5/03/2021

Ticker Name Buffer Level Caps* Outcome Period
BMAY Innovator S&P 500
Buffer ETF™ – May
9.00% 13.60% 12 months
5/01/21 – 4/30/22
PMAY Innovator S&P 500
Power Buffer ETF™ – May
15.00% 8.62% 12 months
5/01/21 – 4/30/22
UMAY Innovator S&P 500
Ultra Buffer ETF™ – May
30.00%
(-5% to -35%)
6.60% 12 months
5/01/21 – 4/30/22

* The Caps above are shown gross of the 0.79% management fee for each ETF. “Cap” refers to the
maximum potential return, before fees and expenses and any shareholder transaction fees and any extraordinary expenses, if held over the full Outcome Period. “Buffer” refers to the amount of downside protection the fund seeks to provide, before fees and expenses, over the full Outcome Period. Outcome Period is the intended length of time over which the defined outcomes are sought. Upon commencement of the Outcome Period, the Caps can be found on a daily basis via www.innovatoretfs.com.

The May Series of the S&P 500 Buffer ETFs reset with large-cap U.S. stocks continuing to reach new records after an extended period of higher-than-average volatility and a historic rally over the past year. Though a significant contingent (67%) of 152 advisors polled by Barron’s for their semi-annual Big Money Poll, published April 26th, describe themselves as “bullish”, those advisors see the S&P 500 Index trading basically flat at 4207 at the end of 2021 and at 4341, about 5% higher than its current level, by the end of June 2022. This highlights the lower upside, range-bound expectations that advisors who are optimistic about equities have for domestic stocks on average and reflects their belief that volatility will persist and increase from current levels1 as the market remains sensitive to monetary policy blunders, tax policy changes, inflation, coronavirus variants and global Covid-19 surges, as well as rising rates. Self-proclaimed “bears” see the S&P 500 trading at 3721 at the end of the year and, similarly, 3723 at the end of June 2022.

“Advisors face a conundrum investing money for risk-averse clients today,” said Bruce Bond, CEO of Innovator ETFs. “Equities are at record highs and bonds don’t pay you much, yet they pack on interest rate risk. Strategists remind us that synchronized monetary and fiscal stimulus could keep the party going but many worry about what could be around the corner after such an impressive run. With 40% of advisors calling the U.S. stock market overvalued, according to the latest Barron’s Big Money Poll, and 65% of those professionals saying it is overvalued by at least 11%, we are finding that many fiduciaries are seeking the comfort of a known buffer against potential market losses over the coming year and the knowledge of a set level of upside participation in the event that stocks continue to climb.”

If held for the full outcome period, Innovator’s Defined Outcome S&P 500 Buffer ETFs – May Series can potentially help advisors capture the gains within the Bull scenario outlined in the Barron’s poll but also provide buffers against a significant portion of the downside forecast in their outlined Bear case, all while decreasing volatility, beta and drawdowns relative to the S&P 500 during the outcome period.

The ETFs reset annually and can be held indefinitely. For additional information, visit the Innovator Defined Outcome ETF Pricing Tool.


Innovator Defined Outcome ETFs – Benefits to Advisors

  • Pioneer and creator of Defined Outcome ETFs™ with 65 ETFs and almost $4.4 billion AUM across family2
  • Tax-efficient exposure to five broad equity benchmarks (S&P 500, NASDAQ-100, Russell 2000, MSCI EAFE, MSCI EM), the 20+ Year U.S. Treasury Market and now including the Stacker ETFs, the world’s first ETFs to offer a “stacked” exposure to two or three benchmark equity index ETFs on the upside, to a cap, with downside exposure to the S&P 500 only, and the Accelerated ETFs™, the world’s first ETFs to seek to offer a multiple of the upside return of a reference asset, up to a cap, with approximately single exposure on the downside.
  • Monthly issuance on the S&P 500 with three buffer levels (9,15, or 30%)

Innovator’s Defined Outcome ETFs™ are the subject of a patent application filed with the U.S. Patent and Trademark Office.

In 2021, starting with the January series, Innovator will be transitioning reference assets of the underlying options within its Defined Outcome Equity Buffer ETFs™ to achieve the stated outcomes with ETF-based, or fund-based, options rather than index-based options. Innovator’s Equity Buffer ETFs™ have traditionally used index-based options while the Defined Outcome Bond ETFs and Stacker ETFs™ have been constructed using fund-based options. This change is intended to streamline market making and increase the operational efficiencies of the tax-efficient Buffer ETFs™ and will not materially impact shareholders. The Buffer ETFs™ will continue to draw from the same deeply liquid options markets pools that underpin the strategies, the level of the upside caps achieved should be unaffected and no tax event will be triggered given the options can be transferred in-kind. “These operational changes are intended to harness the power and efficiencies of the ETF wrapper even further for the benefit of our Defined Outcome Buffer ETF™ investors,” stated Bond.

The Funds have characteristics unlike many other traditional investment products and may not be suitable for all investors. For more information regarding whether an investment in the Fund is right for you, please see “Investor Suitability” in the prospectus.

About Innovator Defined Outcome ETFs
Defined Outcome ETFs™ are the world’s first ETFs that seek to provide investors with known ranges of future investment outcomes prior to investing. These outcome ranges include multiple and single upside exposure, to a cap, with defined levels of downside risk with buffers and floors over a set amount of time. The Innovator Defined Outcome ETFs™ cover a large spectrum of domestic and international equities and bonds. Innovator’s category-creating Defined Outcome ETF™ family includes Buffer ETFs™, Stacker ETFs™ and Floor ETFs™. 

The Buffer ETFs™ seek to provide the upside performance of broadly recognized benchmarks (e.g., S&P 500, NASDAQ-100, Russell 2000, MSCI EAFE, and MSCI Emerging Markets, as well as the iShares 20+ Year Treasury Bond ETF (TLT)) to a cap, with built-in buffers, over an outcome period of one year. The ETFs reset annually and can be held indefinitely.

Each Buffer ETF™ in Innovator’s Defined Outcome ETF™ suite seeks to provide a defined exposure to a broad market benchmark where the downside buffer level, upside growth potential to a cap, and Outcome Period are all known, prior to investing. In 2019, Innovator began expanding its suite of S&P 500 Buffer ETFs™ into a monthly series to provide investors more opportunities to purchase shares as close to the beginning of their respective Outcome Periods as possible.

Investors can purchase shares of a previously listed Defined Outcome ETF™ throughout the entire Outcome Period, obtaining a current set of defined outcome parameters, which are disclosed daily through a web tool available at: http://innovatoretfs.com/define.

Innovator is focused on delivering defined outcome-based solutions inside the benefit-rich ETF wrapper, retaining many of the features that have contributed to the success of structured products3 (e.g., downside buffer levels, upside participation, defined outcome parameters), but with the added benefits of transparency, liquidity, the elimination of credit risk and lower costs afforded by the ETF structure.

About Innovator Capital Management, LLC

Awarded ETF.com’s “ETF Issuer of the Year – 2019”, Innovator Capital Management LLC (Innovator) is an SEC-registered investment advisor (RIA) based in Wheaton, IL. Formed in 2014, the firm is currently headed by ETF visionaries Bruce Bond and John Southard, founders of one of the largest ETF providers in the world. Bond and Southard reentered the asset management industry to bring to market first-of-their-kind investment opportunities, including the Defined Outcome ETFs™, products that they felt would change the investing landscape and bring more certainty to the financial planning process. Innovator’s category-creating Defined Outcome ETF™ family includes Buffer ETFs™, Stacker ETFs™ and Floor ETFs. Buffer ETFs™ and Floor ETFs™ seek to provide investors structured exposures to broad markets, where the upside growth potential, buffer or floor against the downside, and outcome period are all known, prior to investing. Stacker ETFs are the world’s first ETFs to offer a multiple or “stacked” exposure to two or three benchmark index ETFs (SPY, QQQ, IWM) to a cap, with only downside exposure to the SPY over a one year outcome period. Having launched the first Defined Outcome ETFs™ in 2018 — the flagship Innovator S&P 500 Buffer ETF™ Suite – Innovator’s solutions allow advisors to construct diversified portfolios with known outcome ranges to aid in risk management and financial planning. Built on a foundation of innovation and driven by a commitment to help investors better control their financial outcomes, Innovator is leading the Defined Outcome ETF Revolution™. For additional information, visit www.innovatoretfs.com.

About Cboe Global Markets, Inc.
Cboe Global Markets (Cboe: CBOE) is one of the world’s largest exchange-holding companies, offering cutting-edge trading and investment solutions to investors around the world. For more information, visit www.cboe.com.

About Milliman Financial Risk Management LLC

Milliman Financial Risk Management LLC (Milliman FRM) is a global leader in financial risk management to the retirement industry, providing investment advisory, hedging, and consulting services on approximately $150 billion in global assets (as of December 31, 2020). Milliman FRM is one of the largest and fastest-growing subadvisors of ETFs. For more information about Milliman FRM, visit www.Milliman.com/FRM.

Media Contact

Paul Damon
+1 (802) 999-5526
[email protected]

Interim Period Shareholders

Unlike structured notes, which offer limited liquidity, Innovator Defined Outcome ETFs™ trade throughout the day on an exchange, like a stock. As a result, investors purchasing shares of a Fund after its launch date may achieve a different payoff profile than those who entered the Fund on day one. Innovator recognizes this as a benefit of the Funds and provides a web-based tool that allows investors to know, in real-time throughout the trading day, their potential defined outcome return profile before they invest, based on the current ETF price and the Outcome Period remaining. Innovator’s web tool can be accessed at http://www.innovatoretfs.com/define.

Although each Fund seeks to achieve the defined outcomes stated in its investment objective, there is no guarantee that it will do so. The returns that the Funds seek to provide do not include the costs associated with purchasing shares of the Fund and certain expenses incurred by the Fund.

Investing involves risks. Loss of principal is possible. The Funds face numerous market trading risks, including active markets risk, authorized participation concentration risk, buffered loss risk, cap change risk, capped upside return risk, correlation risk, liquidity risk, management risk, market maker risk, market risk, non-diversification risk, operation risk, options risk, trading issues risk, upside participation risk and valuation risk. For a detail list of fund risks see the prospectus.

Market Disruptions Resulting from COVID-19. The outbreak of COVID-19 has negatively affected the worldwide economy, individual countries, individual companies and the market in general. The future impact of COVID-19 is currently unknown, and it may exacerbate other risks that apply to the Fund.

Foreign and Emerging Markets Risk Non-U.S. securities and Emerging Markets are subject to higher volatility than securities of domestic issuers due to possible adverse political, social or economic developments, restrictions on foreign investment or exchange of securities, lack of liquidity, currency exchange rates, excessive taxation, government seizure of assets, different legal or accounting standards, and less government supervision and regulation of securities exchanges in foreign countries.

Technology Sector Risk Companies in the technology sector are often smaller and can be characterized by relatively higher volatility in price performance when compared to other economic sectors. They can face intense competition, which may have an adverse effect on profit margins.

Small-Cap Risk Small-cap companies may be more volatile and susceptible to adverse developments than their mid- and large-cap counterpart. In addition, the small-cap companies may be less liquid than larger companies.

FLEX Options Risk The Fund will utilize FLEX Options issued and guaranteed for settlement by the Options Clearing Corporation (OCC). In the unlikely event that the OCC becomes insolvent or is otherwise unable to meet its settlement obligations, the Fund could suffer significant losses. Additionally, FLEX Options may be less liquid than standard options. In a less liquid market for the FLEX Options, the Fund may have difficulty closing out certain FLEX Options positions at desired times and prices. The values of FLEX Options do not increase or decrease at the same rate as the reference asset and may vary due to factors other than the price of reference asset.

These Funds are designed to provide point-to-point exposure to the price return of the Reference Asset via a basket of Flex Options. As a result, the ETFs are not expected to move directly in line with the Reference Asset during the interim period.

Investors purchasing shares after an outcome period has begun may experience very different results than funds’ investment objective. Initial outcome periods are approximately 1-year beginning on the funds’ inception date. Following the initial outcome period, each subsequent outcome period will begin on the first day of the month the fund was incepted. After the conclusion of an outcome period, another will begin.

Fund shareholders are subject to an upside return cap (the “Cap”) that represents the maximum percentage return an investor can achieve from an investment in the funds’ for the Outcome Period, before fees and expenses. If the Outcome Period has begun and the Fund has increased in value to a level near to the Cap, an investor purchasing at that price has little or no ability to achieve gains but remains vulnerable to downside risks. Additionally, the Cap may rise or fall from one Outcome Period to the next. The Cap, and the Fund’s position relative to it, should be considered before investing in the Fund. The Funds’ website, www.innovatoretfs.com, provides important Fund information as well information relating to the potential outcomes of an investment in a Fund on a daily basis.

The Funds with buffer mechanisms only seek to provide shareholders that hold shares for the entire Outcome Period with their respective buffer level against Reference Asset losses during the Outcome Period. You will bear all Reference Asset losses exceeding 9, 15 or 30%. Depending upon market conditions at the time of purchase, a shareholder that purchases shares after the Outcome Period has begun may also lose their entire investment. For instance, if the Outcome Period has begun and the Fund has decreased in value beyond the pre-determined buffer, an investor purchasing shares at that price may not benefit from the buffer. Similarly, if the Outcome Period has begun and the Fund has increased in value, an investor purchasing shares at that price may not benefit from the buffer until the Fund’s value has decreased to its value at the commencement of the Outcome Period.

THE CORPORATIONS MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO THE PRODUCT(S).

Cboe Global Markets, Inc., and its affiliates do not recommend or make any representation as to possible Benefits from any securities, futures or investments, or third-party products or services. Cboe Global Markets, Inc., is not affiliated with S&P DJI, Milliman, or Innovator Capital Management. Investors should undertake their own due diligence regarding their securities, futures and investment practices.

Cboe Global Markets, Inc., and its affiliates make no warranty, expressed or implied, including, without limitation, any warranties as of merchantability, fitness for a particular purpose, accuracy, completeness or timeliness, or as to the results to be obtained by recipients of the products.

* ETF.com’s editorial team chose the finalists and then the ETF.com Awards Selection Committee, an independent panel comprised of fifteen of the ETF industry’s leading analysts, consultants and investors, decided the winners.

Innovator ETFs™, Defined Outcome ETF™, Buffer ETF™, Enhanced ETF™, Define Your Future™, Leading the Defined Outcome ETF Revolution™ and other service marks and trademarks related to these marks are the exclusive property of Innovator Capital Management, LLC.

The Funds’ investment objectives, risks, charges and expenses should be considered before investing. The prospectus contains this and other important information, and it may be obtained at innovatoretfs.com. Read it carefully before investing.

Innovator ETFs are distributed by Foreside Fund Services, LLC.

Copyright © 2021 Innovator Capital Management, LLC.

800.208.5212        

___________________________________________________________________________________________________________________________

1 The Big Money poll found the average of the 152 advisors’ expectations for the VIX to be at 21.59 at the end of 2021, up from under 20 as of the end of April.

2 AUM in all Innovator Defined Outcome ETFs as of 4.30.2021.

3 Structured notes and structured annuities are financial instruments designed and created to afford investors exposure to an underlying asset through a derivative contract. It is important to note that these ETFs are not structured notes or structured annuities.



Verra Mobility Provides Business Update

PR Newswire

MESA, Ariz., May 3, 2021 /PRNewswire/ — Verra Mobility (NASDAQ: VRRM), a leading provider of smart mobility technology solutions, announces that it has received authorization to proceed with an order for 720 additional school zone speed cameras for the New York City Department of Transportation (“NYCDOT”). This authorization is related to Mayor DeBlasio’s May 24, 2019 announcement regarding NYCDOT’s intention to rapidly and substantially scale up its school zone speed-camera program. Under this expanded program, Verra Mobility has already installed 1,020 speed safety cameras through 2020 and expects to install the additional 720 cameras in 2021. Details on New York City’s Vision Zero program can be found here.     

About Verra Mobility

Verra Mobility is committed to developing and using the latest in technology and data intelligence to help make transportation safer and easier. As a global company, Verra Mobility sits at the center of the mobility ecosystem – one that brings together vehicles, devices, information, and people to solve complex challenges faced by our customers and the constituencies they serve.

Verra Mobility serves the world’s largest commercial fleets and rental car companies to manage tolling transactions and violations for millions of vehicles. As a leading provider of connected systems, Verra Mobility processes millions of transactions each year through integration with more than 50 individual tolling authorities and connectivity with more than 450 issuing authorities. Verra Mobility also fosters the development of safe cities, partnering with law enforcement agencies, transportation departments, and school districts across North America operating thousands of red-light, speed, bus lane, and school bus stop arm safety cameras. Arizona-based Verra Mobility operates in more than 15 countries. For more information, visit www.verramobility.com.

Investor Relations Contact
Sajid Daudi
480-596-2050
[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/verra-mobility-provides-business-update-301281655.html

SOURCE Verra Mobility

1847 Goedeker Inc. Announces Proposed Public Offering of Common Stock

1847 Goedeker Inc. Announces Proposed Public Offering of Common Stock

BALLWIN, Mo.–(BUSINESS WIRE)–
1847 Goedeker Inc. (NYSE American: GOED) (“Goedekers”), a one-stop e-commerce destination for appliances and furniture, announced today that it intends to offer for sale $205,000,000 of its common stock, par value $0.0001 per share (“Common Stock”), in an underwritten public offering. In addition, Goedekers expects to grant the underwriters a 30-day option to purchase an additional $30,750,000 of Common Stock. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

BofA Securities and ThinkEquity, a division of Fordham Financial Management, Inc., are acting as joint-bookrunners for the offering.

Goedekers intends to use the net proceeds from the offering to pay part of the cash portion of the purchase price for the proposed acquisition of Appliances Connection and related acquisition fees and expenses.

A registration statement on Form S-1 (Registration No. 333-255709) (the “Registration Statement”) relating to these securities has been filed with the Securities and Exchange Commission (“SEC”), but has not yet become effective. The securities may not be sold nor may offers to buy be accepted prior to the time that the Registration Statement becomes effective. The offering is being made pursuant to the Registration Statement and an accompanying prospectus. Prospective investors should read the Registration Statement and accompanying prospectus, and the other documents that Goedekers has filed with the SEC for more complete information about Goedekers and the offering. A copy of the preliminary prospectus relating to these securities may be obtained, when available, from BofA Securities, Inc., NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte NC 28255-0001, Attn: Prospectus Department, or by emailing: [email protected]. Electronic copies of the Registration Statement and the accompanying prospectus are also available free of charge on the website of the SEC at www.sec.gov.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

About 1847 Goedeker Inc.

1847 Goedeker Inc. is an industry leading e-commerce destination for appliances, furniture, and home goods. Since its founding in 1951, Goedekers has transformed from a local brick and mortar operation serving the St. Louis metro area to a respected nationwide omnichannel retailer that offers one-stop shopping for national and global brands. While Goedekers maintains its St. Louis showroom, over 95% of sales are placed through its website (www.goedekers.com). Goedekers provides visitors an easy to navigate shopping experience and offers more than 141,000 items organized by category and product features. Learn more at www.goedekers.com.

Forward-Looking Statements

Certain statements made in this press release may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 including, but not limited to, statements regarding the proposed offering. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events or results of operations, are forward-looking statements. These statements may be preceded by, followed by or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates,” “predicts” or “intends” or similar expressions. Such forward-looking statements involve risks and uncertainties that may cause actual events, results or performance to differ materially from those indicated by such statements. Certain of these risks are identified and discussed under “Risk Factors” in the Registration Statement and in Goedekers’ other SEC filings made from time to time. These risk factors are important to consider in determining future results and should be reviewed in their entirety. Forward-looking statements are based on the current belief of Goedekers’ management, based on currently available information, as to the outcome and timing of future events, and involve factors, risks, and uncertainties that may cause actual results in future periods to differ materially from such statements. However, there can be no assurance that the events, results or trends identified in these forward-looking statements will occur or be achieved. Forward-looking statements speak only as of the date they are made, and Goedekers is not under any obligation, and expressly disclaims any obligation, to update, alter or otherwise revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. Readers should carefully review the statements set forth in the reports that Goedekers has filed or will file from time to time with the SEC.

Dave Gentry, CEO

RedChip Companies

Office: 1.800.RED.CHIP (733.2447)

Cell: 407.491.4498

[email protected]

KEYWORDS: Missouri United States North America

INDUSTRY KEYWORDS: Online Retail Home Goods Retail

MEDIA:

Logo
Logo

Cable One Completes Acquisition of Hargray Communications

Cable One Completes Acquisition of Hargray Communications

PHOENIX–(BUSINESS WIRE)–
Cable One, Inc. (NYSE: CABO) (the “Company” or “Cable One”) today announced the completion of its acquisition of the remaining equity interests in Hargray Acquisition Holdings, LLC (“Hargray”) that it did not already own.

Hargray is a leading facilities-based regional communications provider serving nearly 125,000 residential and business customers in 14 markets across Alabama, Florida, Georgia and South Carolina. Hargray offers gigabit-capable services to approximately 99% of its customers. Approximately 60% of Hargray’s total revenues for the 12-month period ended December 31, 2020 were derived from residential data and business services customers.

“We look forward to expanding our footprint into high-quality markets in Florida, Georgia and South Carolina, as well as reentering the Alabama market. The Hargray team has built a reputation of providing superior service and customer support to residential and business customers in these areas and we are excited to further build upon that legacy,” said Julie Laulis, President and CEO of Cable One. “I am thrilled to welcome our new Hargray associates to Cable One as we work together toward our shared focus of connecting customers and communities to what matters most.”

“It has been my privilege to serve as CEO of Hargray for the last 14 years as we have pursued our purpose of empowering people and communities to connect and thrive,” said Michael Gottdenker, Chairman and CEO of Hargray. “I am confident that under Cable One’s ownership we will continue to pursue this purpose for our colleagues, customers and the communities we serve.”

About Cable One

Cable One, Inc. (NYSE: CABO) is a leading broadband communications provider serving more than 1.1 million residential and business customers in 24 states through its Sparklight® and Clearwave® brands. Sparklight provides consumers with a wide array of connectivity and entertainment services, including high-speed internet and advanced Wi-Fi solutions, cable television and phone service. Sparklight Business and Clearwave provide scalable and cost-effective products for businesses ranging in size from small to mid-market, in addition to enterprise, wholesale and carrier customers.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This communication may contain “forward-looking statements” that involve risks and uncertainties. These statements can be identified by the fact that they do not relate strictly to historical or current facts, but rather are based on current expectations, estimates, assumptions and projections about the Company’s industry, business, strategy, acquisitions and strategic investments, dividend policy, financial results and financial condition as well as anticipated impacts from, and the Company’s responses to, the COVID-19 pandemic. Forward-looking statements often include words such as “will,” “should,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” “plans,” “believes” and words and terms of similar substance in connection with discussions of the Company’s expansion into Alabama, Florida, Georgia and South Carolina and future operating or financial performance. As with any projection or forecast, forward-looking statements are inherently susceptible to uncertainty and changes in circumstances. The Company’s actual results may vary materially from those expressed or implied in its forward-looking statements. Accordingly, undue reliance should not be placed on any forward-looking statement made by the Company or on its behalf. Important factors that could cause the Company’s actual results to differ materially from those in its forward-looking statements include government regulation, economic, strategic, political and social conditions and the following factors, which are discussed in the Company’s latest Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”):

  • risks that the Company may fail to realize the benefits anticipated from its acquisition of the remaining equity interests in Hargray;
  • the duration and severity of the COVID-19 pandemic and its effects on the Company’s business, financial condition, results of operations and cash flows;
  • rising levels of competition from historical and new entrants in the Company’s markets;
  • recent and future changes in technology;
  • the Company’s ability to continue to grow its business services products;
  • increases in programming costs and retransmission fees;
  • the Company’s ability to obtain hardware, software and operational support from vendors;
  • risks relating to existing or future acquisitions and strategic investments by the Company;
  • risks that the implementation of the Company’s new enterprise resource planning system disrupts business operations;
  • the integrity and security of the Company’s network and information systems;
  • the impact of possible security breaches and other disruptions, including cyber-attacks;
  • the Company’s failure to obtain necessary intellectual and proprietary rights to operate its business and the risk of intellectual property claims and litigation against the Company;
  • legislative or regulatory efforts to impose network neutrality and other new requirements on the Company’s data services;
  • additional regulation of the Company’s video and voice services;
  • the Company’s ability to renew cable system franchises;
  • increases in pole attachment costs;
  • changes in local governmental franchising authority and broadcast carriage regulations;
  • the potential adverse effect of the Company’s level of indebtedness on its business, financial condition or results of operations and cash flows;
  • the restrictions the terms of the Company’s indebtedness place on its business and corporate actions;
  • the possibility that interest rates will rise, causing the Company’s obligations to service its variable rate indebtedness to increase significantly;
  • risks associated with the Company’s convertible indebtedness;
  • the Company’s ability to continue to pay dividends;
  • provisions in the Company’s charter, by-laws and Delaware law that could discourage takeovers and limit the judicial forum for certain disputes;
  • adverse economic conditions;
  • fluctuations in the Company’s stock price;
  • dilution from equity awards, convertible indebtedness and potential future convertible note and stock issuances;
  • damage to the Company’s reputation or brand image;
  • the Company’s ability to retain key employees;
  • the Company’s ability to incur future indebtedness;
  • provisions in the Company’s charter that could limit the liabilities for directors; and
  • the other risks and uncertainties detailed from time to time in the Company’s filings with the SEC, including but not limited to its latest Annual Report on Form 10-K.

Any forward-looking statements made by the Company in this communication speak only as of the date on which they are made. The Company is under no obligation, and expressly disclaims any obligation, except as required by law, to update or alter its forward-looking statements, whether as a result of new information, subsequent events or otherwise.

Trish Niemann

Senior Director, Corporate Communications

602.364.6372

[email protected]

Steven Cochran

Chief Financial Officer

[email protected]

KEYWORDS: United States North America Arizona

INDUSTRY KEYWORDS: Technology Networks Internet Telecommunications

MEDIA:

Logo
Logo

Chicken Soup for the Soul Entertainment Forms Halcyon Television Led by David Ellender

COS COB, Conn., May 03, 2021 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment, Inc. (Nasdaq: CSSE), one of the leading operators of streaming advertising-supported video-on-demand (AVOD) networks, today announced at the 2021 NewFronts the formation of Halcyon Television. The company will launch Halcyon Television, a high-end premium scripted television studio led by David Ellender as CEO upon the closing of the Sonar asset acquisition that was announced on April 9th, 2020. The closing on the 1,300 title television and film library, scripted development portfolio and the existing TV series drama production is expected to occur in the near future.

“The formation of Halcyon Television will help accelerate our company’s strategy to build the leading independent AVOD network in three ways. It will expand our original content development pipeline with high-end content, increase our IP rights ownership and provide a faster path to growing our international TV production and distribution activities,” said William J. Rouhana Jr, CEO of Chicken Soup for the Soul Entertainment.   

Halcyon Television has a robust drama development pipeline of more than 20 projects embracing library based and original IP sourced in the U.S. and Europe. Halcyon Television will focus on development, financing and production in the U.S. as well as forging creative partnerships in Europe with financing backed by the company and distribution by Halcyon Television’s sister affiliate Screen Media.

“We look forward to building a valued asset library for the company and creating a new vision for the future of TV while continuing the company’s mission of positive entertainment that lifts the human spirit,” said David Ellender, CEO of Halcyon Television. 

Joining Mr. Ellender at Halcyon Television will be Matt Loze as President – Scripted Entertainment, as the first of a number of executives from Sonar who will be brought to Halcyon Television. Mr. Loze added, “Halcyon Television seems a fitting name to highlight a new commitment to supporting artist’s visions in telling moving stories that resonate globally.” 

In addition to aggressively building from IP and library assets, the shared vision of Chicken Soup for the Soul Entertainment and Halcyon Television is to build a nimble and flexible company that will be additive strategically and creatively for partners across the fast-changing TV landscape.

ABOUT CHICKEN SOUP FOR THE SOUL ENTERTAINMENT

Chicken Soup for the Soul Entertainment, Inc. (Nasdaq: CSSE) operates streaming video-on-demand networks (VOD). The company owns Crackle Plus, which owns and operates a variety of ad-supported and subscription-based VOD networks including Crackle, Popcornflix, Popcornflix Kids, Truli, Pivotshare, Españolflix and FrightPix. The company also acquires and distributes video content through its Screen Media subsidiary and produces original long and short-form content through Landmark Studio Group, its Chicken Soup for the Soul Originals division and APlus.com. Chicken Soup for the Soul Entertainment is a subsidiary of Chicken Soup for the Soul, LLC, which publishes the famous book series and produces super-premium pet food under the Chicken Soup for the Soul brand name.

ABOUT HALCYON TELEVISION
Halcyon Television, LLC was created in 2020 by Chicken Soup for the Soul Entertainment, Inc. Led by industry veteran David Ellender, Halcyon Television creates high-end premium scripted television content. The content is distributed by sister affiliate Screen Media Ventures. Projects of Halcyon Television include “Hunters” on Amazon Prime and “Mysterious Benedicts Society” on Disney Plus. Chicken Soup for the Soul Entertainment, Inc. announced the signing of a definitive asset purchase agreement with Sonar Entertainment, Inc. and certain of its subsidiaries by press release on April 9, 2021 and filed with the SEC on that same date a Current Report on Form 8-K summarizing the terms of the proposed asset purchase.

FORWARD-LOOKING STATEMENTS

This press release includes forward-looking statements within the meaning of the federal securities laws. Forward-looking statements are statements that are not historical facts. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of management and are not predictions of actual performance. Forward-looking statements are subject to known and unknown risks and uncertainties, including but not limited to those risks set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. These forward-looking statements speak only as of the date hereof and the Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

INVESTOR RELATIONS
Taylor Krafchik
Ellipsis
[email protected]
(646) 776-0886

MEDIA CONTACT
Kate Barrette
RooneyPartners LLC
[email protected]
(212) 223-0561



1st Constitution Bancorp Reports a 44% Increase in Net Income to $4.9 Million for the First Quarter of 2021 and Declares an 11% Increase in Quarterly Dividend to $0.10 per Share

CRANBURY, N.J., May 03, 2021 (GLOBE NEWSWIRE) — 1ST Constitution Bancorp (NASDAQ: FCCY), the holding company (the “Company”) for 1ST Constitution Bank (the “Bank”), today reported net income of $4.9 million and diluted earnings per share of $0.48 for the three months ended March 31, 2021 compared to net income of $3.4 million and diluted earnings per share of $0.33 for the three months ended March 31, 2020.

The Board of Directors declared a quarterly cash dividend of $0.10 per share of common stock, representing an increase of 11%, compared to the dividend of $0.09 per share of common stock paid on February 26, 2021. The dividend will be paid on May 28, 2021 to shareholders of record on May 14, 2021.

Robert F. Mangano, President and Chief Executive Officer, stated, “Our first quarter financial results reflect our strong operating fundamentals and the Company’s diversified lending platforms as our mortgage warehouse and residential mortgage banking lending operations continued to drive revenue and profitability. We maintained our focus on assisting customers with the SBA PPP lending programs, which resulted in the forgiveness of $34.4 million of existing PPP loans and the funding of $34.2 million of new PPP loans.”

Mr. Mangano added, “We observed improvement in economic conditions in our market in the first quarter of 2021 and anticipate further improvement in economic conditions due to the COVID-19 vaccines becoming more widely distributed and the potential easing of governmental restrictions. We continue to closely monitor the performance of our loan portfolio and believe it was appropriate to strengthen our allowance for loan losses during this period of continuing economic uncertainty caused by the pandemic. Despite the economic uncertainty, our asset quality was stable and only one commercial real estate loan was on deferral at the end of March.”

FIRST QUARTER 2021 HIGHLIGHTS

  • Net income increased $1.5 million, or 44%, to $4.9 million as compared to the first quarter of 2020. Return on average total assets and return on average shareholders’ equity were 1.10% and 10.59%, respectively.
  • Net interest income was $15.3 million and the net interest margin was 3.67% on a tax equivalent basis.
  • A provision for loan losses of $1.4 million was recorded and net recoveries were $3,000.
  • Total loans were $1.3 billion at March 31, 2021 and decreased $138.7 million from December 31, 2020. During the first quarter of 2021, mortgage warehouse lines decreased $120.8 million to $267.6 million at March 31, 2021, reflecting primarily a lower volume of funding of home purchase mortgages due to the seasonal nature of home purchases in the Bank’s market. Residential mortgage loans held in portfolio decreased $13.2 million due to sales and pay-offs of loans.
  • Non-interest income increased $1.6 million for the first quarter of 2021, as residential mortgage banking operations originated $88.2 million of residential mortgages, sold $102.2 million of residential mortgages and recorded a $2.9 million gain on sales of loans.
  • Non-performing assets were $15.4 million, or 0.85% of total assets at March 31, 2021, representing a decrease of $1.9 million from December 31, 2020 and included $48,000 of other real estate owned (“OREO”).

COVID-19 Impact and Response

As the Company conducts its daily operations, the health and safety of our employees and customers remains our primary concern and we continue to maintain the same measures and protective procedures that we implemented in 2020. In addition, the Company is providing paid time off to employees to obtain COVID-19 vaccinations.

During the first quarter of 2021, the Company continued working with customers impacted by the economic disruption. In addition, management increased the allowance for loan losses in response to the higher estimated incurred losses in the loan portfolio. Management may further adjust the provision and allowance for loan losses in response to changes in economic conditions and the performance of the loan portfolio in future periods.

To support our loan and deposit customers and the communities we serve:

  • We continue to provide access to additional credit and forbearance on loan interest and or principal payments for up to 90 days where management has determined that it is warranted. As of March 31, 2021, all loans that had previously received deferrals were no longer deferred, except for two hotel loans that were placed on non-accrual in the second quarter of 2020 and one residential mortgage loan for $871,000 that was placed on non-accrual in the first quarter of 2021. One commercial real estate loan with a balance of $1.4 million received an additional deferral of principal payments up to 90 days in the first quarter of 2021.
  • As a long-standing SBA preferred lender, we actively participated in the SBA’s PPP lending program established under the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”). In 2020, we funded 467 SBA PPP loans totaling $75.6 million, $50.2 million of which had been forgiven by the SBA through the end of the first quarter of 2021.
  • The Economic Aid to Hard-Hit Small Business, Not for Profits and Venues Act (“Economic Aid Act”) was enacted in December 2020 in further response to the COVID-19 pandemic. Among other things, the Economic Aid Act provides relief to borrowers to access additional credit through the SBA’s PPP. We continue to actively participate in the PPP and have accepted 303 applications for PPP loans totaling $35.9 million through April 30, 2021. The SBA has approved 298 of such applications totaling $35.3 million of PPP loans, all of which have been funded.

Modification of Loans and Deferral of Payments

As of March 31, 2021, all commercial business, commercial real estate and consumer loans that had previously received deferrals in 2020 were no longer deferred and had made the contractually due payments, except for two hotel loans totaling $4.6 million that were placed on non-accrual in the third quarter of 2020 and one residential mortgage loan for $871,000 that was placed on non-accrual in the first quarter of 2021. One commercial real estate loan with a balance of $1.4 million received an additional deferral of principal payments up to 90 days in the first quarter of 2021.

Allowance for Loan Losses

Management reviewed the loan portfolio at March 31, 2021 in connection with the evaluation of the adequacy of the allowance for loan losses. As part of this review, management reviewed over 98% of the $132.1 million of commercial business and commercial real estate loans that had been modified to defer interest and or principal for up to 90 days in 2020 and 2021. Loans with balances of less than $250,000 were generally excluded from management’s review. As a result of management’s review of the loan portfolio at March 31, 2021, a provision for loan losses of $1.4 million was recorded for the first quarter of 2021 and the allowance for loan losses was increased to $17.0 million at March 31, 2021. The provision for loan losses reflected primarily a $1.7 million increase in specific reserves to $3.8 million for impaired loans.

At March 31, 2021, the allowance for loan losses included $649,000 for loans that were rated Pass-Watch and had received a deferral. This reflects management’s previously reported determination that “Pass-Watch” credit rated loans with modifications or deferrals suggest a weaker financial strength of the borrower than “Pass” credit rated loans, thereby warranting additional reserves for loan losses than would ordinarily be reserved for “Pass-Watch” credit rated loans.

Within the loan portfolio, hotel and restaurant-food service industries have been adversely impacted by the economic disruption caused by the COVID-19 pandemic. At March 31, 2021 loans to hotel and restaurant-food service industries were $67.8 million and $64.4 million, respectively. Management reviewed over 99% of the hotel loans and over 93% of the restaurant-food service loans.

All construction loans are closely monitored on a quarterly basis and are reviewed to assess the progress of construction relative to the plan and budget and lease-up or sales of units.

Management also reviewed loans to schools that are private educational institutions that are generally sponsored or affiliated with religious organizations. These loans totaled $24.6 million at March 31, 2021, and 98% of these loans were reviewed.

The expanded review also included $6.3 million, or over 40%, of commercial loans made under the SBA 7(a) loan program, totaling $15.5 million at March 31, 2021.

As a result of this first quarter of 2021 review, loans totaling $3.2 million and $871,000 were down-graded to “Special Mention” and “Substandard,” respectively. In addition, a $2.8 million shared national credit loan was down-graded to “Substandard.”

Discussion of Financial Results

Net income was $4.9 million, or $0.48 per diluted share, for the first quarter of 2021 compared to net income of $3.4 million, or $0.33 per diluted share, for the first quarter of 2020. For the three months ended March 31, 2021, net interest income increased $2.3 million compared to the three months ended March 31, 2020 driven primarily by the increase in the average balance of loans since March 31, 2020. Gain on sales of loans for the first quarter of 2021 increased $1.6 million compared to the first quarter of 2020 due primarily to the higher volume of residential mortgage loans sold. The provision for loan losses was $1.4 million for the first quarter of 2021 compared to $895,000 for the first quarter of 2020. This increase reflected management’s estimate of loan losses that were incurred due to the economic disruption caused by the COVID-19 pandemic and changes in the mix and risk factors of the loan portfolio. Non-interest expenses were $11.1 million for the first quarter of 2021, representing an increase of $1.3 million compared to $9.8 million for the first quarter of 2020.

Net interest income was $15.3 million for the first quarter of 2021 and increased $2.3 million compared to net interest income of $12.9 million for the first quarter of 2020. Total interest income was $17.0 million for the three months ended March 31, 2021 compared to $16.4 million for the three months ended March 31, 2020. The increase in total interest income was primarily due to a net increase of $170.6 million in average loans, reflecting growth in commercial real estate, mortgage warehouse and commercial business loans, including SBA PPP loans. Average interest-earning assets were $1.7 billion, with a tax-equivalent yield of 4.07%, for the first quarter of 2021 compared to average interest-earning assets of $1.4 billion, with a tax-equivalent yield of 4.66% for the first quarter of 2020. The tax-equivalent yield on average interest-earning assets for the first quarter of 2021 declined 59 basis points to 4.07%, due primarily to the decline in market interest rates during 2020 to a low level that continued through the first quarter of 2021 and the higher average balance of federal funds sold/short-term investments with a yield of 0.10%. The Federal Reserve reduced the targeted federal funds rate 150 basis points in March 2020 in response to the economic uncertainty resulting from the COVID-19 pandemic. As a result of the reductions in the targeted federal funds rate, the prime rate declined to 3.25% in March 2020 and was unchanged through the first quarter of 2021. The Bank had approximately $455.5 million of loans with an interest rate tied to the prime rate and approximately $49.3 million of loans with an interest rate tied to either 1- or 3-month LIBOR at March 31, 2021.

Interest expense on average interest-bearing liabilities was $1.7 million, with an interest cost of 0.59%, for the first quarter of 2021, compared to $2.0 million, with an interest cost of 0.65%, for the fourth quarter of 2020 and $3.5 million, with an interest cost of 1.30%, for the first quarter of 2020. Despite an increase of $94.7 million in average interest-bearing liabilities for the first quarter of 2021 compared to the first quarter of 2020, interest expense declined $1.8 million due largely to the decline in interest rates paid on deposits and the redeemable subordinated debentures as a direct result of the lower interest rate environment. The average cost of interest-bearing deposits was 0.57% for the first quarter of 2021, 0.64% for the fourth quarter of 2020 and 1.27% for the first quarter of 2020. The lower interest cost of interest-bearing deposits for the first quarter of 2021 compared to the first quarter of 2020 reflected primarily lower market interest rates since March 2020. The interest rates paid on deposits generally do not adjust quickly to rapid changes in market interest rates and decline over time in a falling interest rate environment. Of the total increase in average interest-bearing liabilities, money market and NOW accounts increased $56.9 million, savings accounts increased $89.3 million and certificates of deposit and short-term borrowings decreased $33.0 million and $18.6 million, respectively, for the first quarter of 2021. At March 31, 2021, there were $135.1 million of retail certificates of deposits with an average interest cost of 1.20% that mature within the following 12 months. Management will continue to monitor and adjust the interest rates paid on deposits to reflect the then current interest rate environment and competitive factors.

The net interest margin on a tax-equivalent basis was 3.67% for the first quarter of 2021 compared to 3.68% for the first quarter of 2020. The net interest margin for the first quarter of 2021 was negatively impacted by the higher average balance of federal funds sold/short-term investments resulting from the growth in the average balance of deposits. Interest income for the first quarter of 2021 included $398,000 of fee income related to PPP loans that were forgiven and paid-off by the SBA, $151,000 of interest income collected on a PCI commercial real estate loan that was paid-off and $50,000 of prepayment fees collected on commercial real estate loans that were paid-off. Excluding the effect of the higher average balance of federal funds sold/short-term investments, the net interest margin was approximately 3.95% for the first quarter of 2021.

The Company recorded a provision for loan losses of $1.4 million for the first quarter of 2021 compared to a provision for loan losses of $895,000 for the first quarter of 2020. The increase in the provision for loan losses in the first quarter of 2021 reflected primarily a $1.6 million increase in specific reserves on impaired loans. This provision also reflected changes in loan ratings and mix of the loan portfolio at March 31, 2021. At March 31, 2021, total loans were $1.3 billion and the allowance for loan losses was $17.0 million, or 1.32% of total loans, compared to total loans of $1.2 billion and an allowance for loan losses of $10.0 million, or 0.82% of total loans, at March 31, 2020. The allowance for loan losses, excluding the allocated reserve for mortgage warehouse lines, was $15.8 million, or 1.54% of total loans excluding mortgage warehouse lines at March 31, 2021. In addition, at March 31, 2021, there were $59.5 million of SBA PPP loans which are 100% guaranteed by the SBA and, accordingly, no reserve was provided.

Non-interest income was $4.1 million for the first quarter of 2021, representing an increase of $1.6 million, or 66.0%, compared to $2.5 million for the first quarter of 2020. The significant increase in non-interest income was driven primarily by a $1.6 million increase in gain on sales of loans. In the first quarter of 2021, residential mortgage banking operations originated $88.2 million of residential mortgages, sold $102.2 million of residential mortgages and recorded a $2.9 million gain on sales of loans compared to $73.4 million of residential mortgages originated, $34.0 million of residential mortgage loans sold and a $1.2 million gain on sales of loans recorded in the first quarter of 2020. The residential mortgage loan pipeline was $32.1 million at March 31, 2021. Management believes that the increase in residential mortgage loans originated and sold was due primarily to increased residential mortgage refinancing activity as a result of continued lower mortgage interest rates. In the first quarter of 2021, $1.8 million of SBA loans were sold and gains of $190,000 were recorded compared to $2.7 million of SBA loans sold and gains of $226,000 recorded in the first quarter of 2020. Service charges on deposit accounts decreased $96,000 for the first quarter of 2021 compared to the first quarter of 2020, due primarily to lower overdraft fees. Other income increased $105,000 in the first quarter of 2021 compared to the first quarter of 2020 due primarily to recoveries on PCI loans in excess of the fair value of the acquired loans.

Non-interest expenses were $11.1 million for the first quarter of 2021 and increased $1.3 million, or 13.4%, compared to $9.8 million for the first quarter of 2020. Salaries and employee benefits expense increased $783,000 or 12.7%, for the first quarter of 2021 compared to the first quarter of 2020 due primarily to a $729,000 increase in mortgage commissions resulting from significantly higher residential mortgage lending activity, $75,000 in temporary staffing costs and $171,000 in merit increases and increases in employee benefit expenses, which were partially offset by higher deferred loan origination expenses of approximately $180,000. Occupancy expense increased $141,000 in the first quarter of 2021 compared to the first quarter of 2020 primarily due to higher snow removal costs. FDIC insurance expense increased $236,000 due to the growth of assets, a credit of $106,000 from the FDIC related to the fourth quarter of 2019 assessment and a higher FDIC assessment rate in the first quarter of 2021 compared to the assessment rate in the first quarter of 2020. Other operating expenses increased $68,000, or 3.5%, for the first quarter of 2021 compared to the first quarter of 2020, resulting primarily from net increases in various components of other operating expenses.

Income tax expense was $1.9 million for the first quarter of 2021, resulting in an effective tax rate of 28.1%, compared to income tax expense of $1.3 million, which resulted in an effective tax rate of 27.3% for the first quarter of 2020. The increase in income tax expense was due to an increase of $2.2 million in pre-tax income in the first quarter of 2021 compared to the first quarter of 2020. The higher effective tax rate in the first quarter of 2021 reflected the higher New Jersey statutory tax rate in effect compared to the statutory tax rate in effect in the first quarter of 2020.

Total assets were $1.81 billion at March 31, 2021, relatively unchanged from December 31, 2020. Total cash and cash equivalents increased $143.9 million and total investment securities increased $8.5 million, which amounts were offset by decreases of $138.7 million in total portfolio loans and $14.1 million in loans held for sale. Total portfolio loans at March 31, 2021 were $1.29 billion, compared to $1.43 billion at December 31, 2020. The $138.7 million decrease in portfolio loans was due primarily to a decrease of $120.8 million in mortgage warehouse lines as a result of lower funding volume, a decrease of $10.9 million in commercial real estate loans as a result of pay-offs and a decrease of $13.2 million in residential real estate loans, and was partially offset by a $9.7 million increase in construction loans. Loans held for sale decreased $14.1 million due to loan sales in excess of originations. Total investment securities were $226.3 million at March 31, 2021, representing an increase of $8.5 million from $217.7 million at December 31, 2020. Investment securities available for sale increased $5.7 million and investment securities held to maturity increased $2.8 million at March 31, 2021 from December 31, 2020.

Total deposits were $1.56 billion at March 31, 2021, relatively unchanged from December 31, 2020. Non-interest-bearing demand deposits increased $44.1 million due in part to funding of the SBA PPP loans while interest-bearing deposits decreased $45.7 million. Of the total decrease in interest-bearing deposits, certificates of deposit decreased $95.2 million primarily due to the maturity of $72 million of short-term internet listing service certificates of deposit. Savings deposits increased $42.5 million and interest-bearing demand deposits increased $7.0 million. There were no short-term borrowings at March 31, 2021 compared to $9.8 million at December 31, 2020.

Regulatory capital ratios for the Company and the Bank continue to reflect a strong capital position. Under applicable regulatory capital standards, the Company’s estimated common equity Tier 1 to risk-based assets (“CET1”), total risk-based capital, Tier I capital, and leverage ratios were 10.89%, 13.37%, 12.16% and 9.64%, respectively, at March 31, 2021. The Bank’s estimated CET1, total risk-based capital, Tier 1 capital and leverage ratios were 12.16%, 13.37%, 12.16% and 9.63%, respectively, at March 31, 2021. The Company and the Bank are considered “well capitalized” under these capital standards.

Asset Quality

Non-accrual loans were $15.3 million at March 31, 2021 compared to $16.4 million at December 31, 2020. During the quarter ended March 31, 2021, $967,000 of loans were placed on non-accrual status and consisted of a $96,000 home equity loan and an $871,000 residential mortgage loan. During the first quarter of 2021, $2.0 million of non-performing loans were resolved as a result of pay-downs and pay-offs, which included $782,000 of purchased credit impaired loans that were repaid.

Non-performing loans represented 1.18% of total loans and non-performing assets represented 0.85% of total assets at March 31, 2021 compared to 1.20% and 0.96% at December 31, 2020, respectively.

OREO decreased $44,000 to $48,000 at March 31, 2021 compared to $92,000 at December 31, 2020, due to the write-down of the asset. The asset consisted of one parcel of land.

About 1

ST

Constitution Bancorp

1ST Constitution Bancorp, through its primary subsidiary, 1ST Constitution Bank, operates 25 branch banking offices in Asbury Park, Cranbury (2), Fair Haven, Fort Lee, Freehold, Hamilton, Hightstown, Hillsborough, Hopewell, Jackson, Jamesburg, Lawrenceville, Little Silver, Long Branch, Manahawkin, Neptune City, Perth Amboy, Plainsboro, Princeton, Rocky Hill, Rumson, Shrewsbury and Toms River (2), New Jersey.

1ST Constitution Bancorp is traded on the Nasdaq Global Market under the trading symbol “FCCY” and information about the Company can be accessed through the Internet at www.1STCONSTITUTION.com

Cautionary Language Concerning Forward-Looking Statements

The foregoing contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 relating to, without limitation, our future economic performance, plans and objectives for future operations, and projections of revenues and other financial items that are based on our beliefs, as well as assumptions made by and information currently available to us. The words “may,” “will,” “anticipate,” “should,” “would,” “believe,” “contemplate,” “could,” “project,” “predict,” “expect,” “estimate,” “continue,” and “intend,” as well as other similar words and expressions of the future, are intended to identify forward-looking statements.

These forward-looking statements are based upon our opinions and estimates as of the date they are made and are not guarantees of future performance. Although we believe that the expectations reflected in these forward-looking statements are reasonable, such forward-looking statements are subject to known and unknown risks and uncertainties that may be beyond our control, which could cause actual results, performance and achievements to differ materially from results, performance and achievements projected, expected, expressed or implied by the forward-looking statements.

Examples of factors or events that could cause actual results to differ materially from historical results or those anticipated, expressed or implied include, without limitation, changes in the overall economy and interest rate changes; inflation, market and monetary fluctuations; the ability of our customers to repay their obligations; the accuracy of our financial statement estimates and assumptions, including the adequacy of the estimates made in connection with determining the adequacy of the allowance for loan losses; increased competition and its effect on the availability and pricing of deposits and loans; significant changes in accounting, tax or regulatory practices and requirements; changes in deposit flows, loan demand or real estate values; the enactment of legislation or regulatory changes; changes in monetary and fiscal policies of the U.S. government; changes to the method that LIBOR rates are determined and to the phasing out of LIBOR after 2021; changes in loan delinquency rates or in our levels of non-performing assets; our ability to declare and pay dividends; changes in the economic climate in the market areas in which we operate; the frequency and magnitude of foreclosure of our loans; changes in consumer spending and saving habits; the effects of the health and soundness of other financial institutions, including the need of the FDIC to increase the Deposit Insurance Fund assessments; technological changes; the effects of climate change and harsh weather conditions, including hurricanes and man-made disasters; the economic impact of any future terrorist threats and attacks, acts of war or threats thereof and the response of the United States to any such threats and attacks; our ability to integrate acquisitions and achieve cost savings; other risks described from time to time in our filings with the Securities and Exchange Commission; and our ability to manage the risks involved in the foregoing. Further, the foregoing factors may be exacerbated by the ultimate impact of the COVID-19 pandemic, which is unknown at this time.

In addition, statements about the COVID-19 pandemic and the potential effects and impacts of the COVID-19 pandemic on the Company’s business, financial condition, liquidity and results of operations may constitute forward-looking statements and are subject to the risk that actual results may differ, possibly materially, from what is reflected in such forward-looking statements due to factors and future developments that are uncertain, unpredictable and, in many cases, beyond our control, including the scope, duration and extent of the pandemic, actions taken by governmental authorities in response to the pandemic and the direct and indirect impact of the pandemic on our employees, customers, business and third-parties with which we conduct business.

Although management has taken certain steps to mitigate any negative effect of the aforementioned factors, significant unfavorable changes could severely impact the assumptions used and have an adverse effect on profitability. Any forward-looking statements made by us or on our behalf speak only as of the date they are made, and we do not undertake any obligation to update any forward-looking statement to reflect the impact of subsequent events or circumstances, except as required by law.





1

ST

Constitution Bancorp

Selected Consolidated Financial Data

(Dollars in thousands, except per share data)

(Unaudited)

  Three Months Ended March 31,
  2021   2020
Per share data:      
Earnings per share – basic $ 0.48       $ 0.34    
Earnings per share – diluted 0.48       0.33    
Book value per share at end of period 18.63       16.97    
Tangible book value per common share at end of period(1) 15.13       13.38    
       
Weighted average shares outstanding – basic 10,261,718       10,200,836    
Weighted average shares outstanding – diluted 10,307,559       10,262,047    
Shares outstanding at end of period 10,265,163       10,201,298    
Performance ratios/data:      
Return on average total assets 1.10   %   0.89   %
Return on average shareholders’ equity 10.59   %   8.01   %
Net interest income (tax-equivalent basis)(2) $ 15,405       $ 13,053    
Net interest margin (tax-equivalent basis)(3) 3.67   %   3.68   %
Efficiency ratio (tax-equivalent basis)(4) 56.98   %   63.14   %
       
Loan portfolio composition: March 31, 2021   December 31, 2020
Commercial real estate $ 608,033       $ 618,978    
Mortgage warehouse lines 267,580       388,366    
Construction loans 138,924       129,245    
Commercial business 187,389       188,728    
Residential real estate 75,048       88,261    
Loans to individuals 19,441       21,269    
Other loans 103       113    
Gross loans 1,296,518       1,434,960    
Deferred (fees) costs, net (1,530 )     (1,254 )  
Total loans $ 1,294,988       $ 1,433,706    
Asset quality data:      
Loans past due over 90 days and still accruing $       $ 871    
Non-accrual loans 15,333       16,361    
OREO property 48       92    
Total non-performing assets $ 15,381       $ 17,324    
       
Net recoveries (charge-offs) $ 3       $ (328 )  
Allowance for loan losses to total loans 1.32   %   1.09   %
Allowance for loan losses to total loans excluding mortgage
  warehouse lines and related allowance
1.54   %   1.32   %
Allowance for loan losses to non-performing loans 111.16   %   90.77   %
Non-performing loans to total loans 1.18   %   1.20   %
Non-performing assets to total assets 0.85   %   0.96   %
Capital ratios:      
1

ST

Constitution Bancorp
     
Common equity tier 1 capital to risk-weighted assets 10.89   %   9.92   %
Total capital to risk-weighted assets 13.37   %   12.16   %
Tier 1 capital to risk-weighted assets 12.16   %   11.12   %
Tier 1 leverage ratio 9.64   %   9.41   %
1

ST

Constitution Bank
     
Common equity tier 1 capital to risk-weighted assets 12.16   %   11.11   %
Total capital to risk-weighted assets 13.37   %   12.15   %
Tier 1 capital to risk-weighted assets 12.16   %   11.11   %
Tier 1 leverage ratio 9.63   %   9.40   %

(1) Tangible book value per common share is a non-GAAP financial measure and is calculated by subtracting goodwill and other intangible assets from shareholders’ equity and dividing it by common shares outstanding.
(2) The tax-equivalent adjustment was $127 and $117 for the three months ended March 31, 2021 and 2020, respectively.
(3) Represents net interest income on a tax-equivalent basis as a percent of average interest-earning assets.
(4) Represents non-interest expenses divided by the sum of net interest income on a tax-equivalent basis and non-interest income.





1

ST

Constitution Bancorp

Consolidated Balance Sheets

(Dollars in thousands)

(Unaudited)

  March 31, 2021   December 31, 2020
ASSETS      
Cash and due from banks $ 7,483     $ 3,661  
Interest-earning deposits 158,418     18,334  
Total cash and cash equivalents 165,901     21,995  
Investment securities:      
Available for sale, at fair value 130,897     125,197  
Held to maturity (fair value of $97,899 and $95,640 at March 31,
  2021 and December 31, 2020, respectively)
95,371     92,552  
Total investment securities 226,268     217,749  
Loans held for sale 15,679     29,782  
Loans 1,294,988     1,433,706  
Less: allowance for loan losses (17,044 )   (15,641 )
Net loans 1,277,944     1,418,065  
Premises and equipment, net 14,207     14,345  
Right-of-use assets 16,121     16,548  
Accrued interest receivable 4,663     5,273  
Bank-owned life insurance 37,490     37,316  
Other real estate owned 48     92  
Goodwill and intangible assets 35,922     36,003  
Other assets 11,988     9,741  
Total assets $ 1,806,231     $ 1,806,909  
LIABILITIES AND SHAREHOLDERS’ EQUITY      
LIABILITIES      
Deposits      
Non-interest bearing $ 469,339     $ 425,210  
Interest bearing 1,091,880     1,137,629  
Total deposits 1,561,219     1,562,839  
Short-term borrowings     9,825  
Redeemable subordinated debentures 18,557     18,557  
Accrued interest payable 699     851  
Lease liability 16,993     17,387  
Accrued expense and other liabilities 17,500     9,793  
Total liabilities 1,614,968     1,619,252  
SHAREHOLDERS EQUITY      
Preferred stock, no par value; 5,000,000 shares authorized;   none issued      
Common stock, no par value; 30,000,000 shares authorized; 10,320,866 and 10,293,535 shares issued and 10,265,163 and 10,245,826 shares outstanding as of March 31, 2021 and December 31, 2020, respectively 111,460     111,135  
Retained earnings 79,208     75,201  
Treasury stock, 55,703 and 47,709 shares at March 31, 2021 and December 31, 2020, respectively (739 )   (611 )
Accumulated other comprehensive income 1,334     1,932  
Total shareholders’ equity 191,263     187,657  
Total liabilities and shareholders’ equity $ 1,806,231     $ 1,806,909  





1

ST

Constitution Bancorp

Consolidated Statements of Income

(Dollars in thousands, except per share data)

(Unaudited)

  Three Months Ended

March 31,
  2021   2020
INTEREST INCOME      
Loans, including fees $ 15,925     $ 14,805  
Securities:      
Taxable 520     1,056  
Tax-exempt 478     438  
Federal funds sold and short-term investments 37     89  
Total interest income 16,960     16,388  
INTEREST EXPENSE      
Deposits 1,598     3,238  
Borrowings     62  
Redeemable subordinated debentures 84     152  
Total interest expense 1,682     3,452  
Net interest income 15,278     12,936  
PROVISION FOR LOAN LOSSES 1,400     895  
Net interest income after provision for loan losses 13,878     12,041  
NON-INTEREST INCOME      
Service charges on deposit accounts 117     213  
Gain on sales of loans, net 3,095     1,470  
Income on bank-owned life insurance 174     180  
Gain on sales/calls of securities 2     8  
Other income 690     585  
Total non-interest income 4,078     2,456  
NON-INTEREST EXPENSES      
Salaries and employee benefits 6,952     6,169  
Occupancy expense 1,311     1,170  
Data processing expenses 491     446  
FDIC insurance expense 270     34  
Other real estate owned expenses 52     17  
Other operating expenses 2,025     1,957  
Total non-interest expenses 11,101     9,793  
Income before income taxes 6,855     4,704  
INCOME TAXES 1,926     1,283  
Net income $ 4,929     $ 3,421  
EARNINGS PER COMMON SHARE      
Basic $ 0.48     $ 0.34  
Diluted 0.48     0.33  
WEIGHTED AVERAGE SHARES OUTSTANDING      
Basic 10,261,718     10,200,836  
Diluted 10,307,559     10,262,047  

1

ST

Constitution Bancorp

Net Interest Margin Analysis

(Unaudited)

  Three months ended March 31, 2021   Three months ended March 31, 2020
(In thousands except yield/cost information) Average       Average   Average       Average
Assets Balance   Interest   Yield/Cost   Balance   Interest   Yield/Cost
Interest-earning assets:                      
Federal funds sold/short term investments $ 147,948     $ 37     0.10 %   $ 24,557     $ 89     1.46 %
Investment securities:                      
Taxable 129,217     520     1.61 %   168,376     1,056     2.51 %
Tax-exempt (1) 88,800     605     2.73 %   65,194     555     3.40 %
Total investment securities 218,017     1,125     2.06 %   233,570     1,611     2.76 %
Loans: (2)                      
Commercial real estate 612,363     7,677     5.01 %   574,640     7,355     5.06 %
Mortgage warehouse lines 279,739     2,785     3.98 %   175,275     2,035     4.64 %
Construction 133,160     1,822     5.47 %   147,496     2,179     5.94 %
Commercial business 128,481     1,272     4.02 %   142,793     1,803     5.08 %
SBA PPP loans 61,610     1,023     6.73 %           %
Residential real estate 81,020     949     4.69 %   90,360     996     4.36 %
Loans to individuals 19,490     220     4.58 %   30,497     392     5.08 %
Loans held for sale 22,158     170     3.07 %   3,986     35     3.51 %
All other loans 563     7     4.97 %   1,350     10     2.96 %
Deferred (fees) costs, net (1,141 )       %   453         %
Total loans 1,337,443     15,925     4.83 %   1,166,850     14,805     5.10 %
Total interest-earning assets 1,703,408     $ 17,087     4.07 %   1,424,977     $ 16,505     4.66 %
Non-interest-earning assets:                      
Allowance for loan losses (16,044 )           (9,454 )        
Cash and due from bank 12,513             13,383          
Other assets 119,620             122,482          
Total non-interest-earning assets 116,089             126,411          
   Total assets $ 1,819,497             $ 1,551,388          
Liabilities and shareholders’ equity:                      
Interest-bearing liabilities:                      
Money market and NOW accounts $ 458,734     $ 464     0.41 %   $ 401,837     $ 760     0.76 %
Savings accounts 354,378     427     0.49 %   265,053     604     0.92 %
Certificates of deposit 326,930     707     0.88 %   359,881     1,874     2.09 %
Short-term borrowings 328         %   18,915     62     1.32 %
Redeemable subordinated debentures 18,557     84     1.81 %   18,557     152     3.24 %
Total interest-bearing liabilities 1,158,927     $ 1,682     0.59 %   1,064,243     $ 3,452     1.30 %
Non-interest-bearing liabilities:                      
Demand deposits 440,632             283,520          
Other liabilities 31,252             31,793          
Total non-interest-bearing liabilities 471,884             315,313          
Shareholders’ equity 188,686             171,832          
   Total liabilities and
     shareholders’ equity
$ 1,819,497             $ 1,551,388          
Net interest spread (3)         3.48 %           3.36 %
Net interest income and margin (4)     $ 15,405     3.67 %       $ 13,053     3.68 %

(1) Tax-equivalent basis, using 21% federal tax rate in 2021 and 2020.
(2) Loan origination fees and costs are considered an adjustment to interest income. For the purpose of calculating loan yields, average loan balances include non-accrual loans with no related interest income and the average balance of loans held for sale.
(3) The net interest spread is the difference between the average yield on interest-earning assets and the average rate paid on interest-bearing liabilities.
(4) The net interest margin is equal to net interest income divided by average interest-earning assets.

CONTACT: Robert F. Mangano Stephen J. Gilhooly
  President & Chief Executive Officer Sr. Vice President & Chief Financial Officer
  (609) 655-4500 (609) 655-4500



Genius Brands’ “Stan Lee’s Superhero Kindergarten” Surpasses 9 Million Views on Kartoon Channel!

Schwarzenegger and Exciting Storyline Driving Exponential Growth Across All Key Metrics

BEVERLY HILLS, Calif., May 03, 2021 (GLOBE NEWSWIRE) — The April 23 premiere of Genius Brands International, Inc.’s (“Genius Brands”) (NASDAQ:GNUS) Stan Lee’s Superhero Kindergarten, has proven to be a huge hit for Kartoon Channel!, with over 9 million views to date.

“Superhero Kindergarten analytics from Kartoon Channel! from the first weekend, exceeded all expectations, with traffic up across every metric we track,” said Kartoon Channel! General Manager, Jon Ollwerther.


“Network hours watched


went up 941%
week-over-week to 349,735 hours. Unique userswent up 1,841% week-over-week to 1,858,434 uniques. New application installs went up 465.9%, as we saw growth across all viewing outlets including televisions, tablets, mobile phones, computers, and game consoles, as well as growth across all the viewing platforms of Kartoon Channel!, including Apple, Android, Roku, Amazon, You Tube, Samsung, LG, and others, with full episode viewing exceeding industry norms as well. We can already see the 2nd weekend dramatically building on the 1st.”

Celebrating the Superhero Kindergarten milestone, Schwarzenegger stated: “Over 9 million views is an incredible start in this wonderful adventure, and I know that Stan would be extremely proud. I’m personally quite pleased, because it is positive content, for both kids and their parents. As Kelly Clarkson said this week on her show after airing a clip, ‘I love when a program comes out that my kids want to watch, and I want to watch as well. ” (Click to view Arnold Schwarzenegger’s recent appearances on The Kelly Clarkson Show and Jimmy Kimmel Live!)

“The world is migrating to streaming, and being free and family friendly, are distinguishing factors to drive Kartoon Channel! success,” said Genius Brands CEO, Andy Heyward. “Warren Buffett calls this type of differentiation a ‘moat,’ where an economic castle enjoys a material competitive advantage. There is no monthly subscription fee on Kartoon Channel!, as is required by many streaming services, because we are ad-supported. No less important is that we are producing very cool original content of the highest quality, which today’s kids and families want to see.”

“The importance of the Superhero Kindergarten performance is that successful viewership drives advertising revenue to the Kartoon Channel!, making the channel the valuable asset for Genius Brands we have been aiming towards from its launch. Second, retailers, toy companies, and consumer product licensees track series performance closely, as they determine what brands they go after and devote shelf space to. Though we can’t compare apples to oranges, the most successful animated series on television for many years has been the Simpsons. It is broadcast on linear television, and averages about 3.1 million views per episode. While, Superhero Kindergarten is streaming, not linear television, we couldn’t help but notice that by the end of the second weekend, the series has amassed more than 9 million views with only 3 episodes released so far.”

Genius Brands will continue rolling out new episodes each week with episode four debuting this Friday! The series is available by downloading the free Kartoon Channel! streaming app on Apple and Android devices; on Amazon Prime, on connected TVs and devices by Samsung, LG, Roku, Tubi, Amazon Fire Stick; on YouTube; and more; or by visiting www.kartoonchannel.com.

Stan Lee’s Superhero Kindergarten is geared towards kids and families and focuses on the adventures of six unique kids who are learning to master their super skills, along with their ABCs. With the help of their teacher Arnold Armstrong (AKA ‘Captain Fantastic’, the greatest superhero to ever live!).

It all began five years ago when Arnold Armstrong faced off in a final fight against his nemesis, the evil Dr. Superior, that left him powerless. Little did anyone know that during the fight, super-energy particles rained down on a group of unsuspecting toddlers. Now, those toddlers are kindergarten students at Greenville Elementary School who, with the help of Arnold Armstrong, must learn to control their powers as they go on super adventures! Arnold Armstrong’s mission: to train these kids to use their super-powers safely without revealing their identities. They learn the values of teamwork, health, diversity and anti-bullying while also protecting their town from rivals, and the nefarious Dr. Superior who has returned as Headmaster Danforth of the Academy for Superior Children across town.

Fun for the whole family, the series opens up the superhero genre for a whole new demographic and draws kids in with action and comedy, while parents can appreciate the quality of content synonymous with Stan Lee. Season one of the series includes 26 half-hour long episodes that began with a two-episode double feature and will be rolled out on a weekly basis every Friday.

Stan Lee’s Superhero Kindergarten features Schwarzenegger, voice-directed by John Landis, one of the most successful movie directors of all time, with Steven Banks, former head writer for SpongeBob SquarePants, serving as head writer for the series. The series is produced by Genius Brands and Stan Lee’s POW! Entertainment in association with Schwarzenegger’s Oak Productions. Gill Champion, CEO of Stan Lee’s POW! Entertainment; Andy Heyward, Chairman & CEO of Genius Brands; Schwarzenegger; and Paul Wachter of Main Street Advisors serve as executive producers.

About Kartoon Channel!

Available everywhere and anywhere kids are today, Genius Brands’ streaming network, Kartoon Channel!, is a family entertainment destination that delivers enduring childhood moments of humor, adventure, and discovery.

Delivering 1000’s of episodes of carefully curated free family-friendly content, the channel features animated classics for little kids, including The Wubbulous World of Dr. Seuss, Babar, Mello Dees, Super Simple Songs and Baby Genius, and hit content for bigger kids, such as Pac-Man, Angry Birds, and Yu-Gi-Oh, to original programming like Stan Lee’s Superhero Kindergarten, starring Arnold Schwarzenegger, KC! Pop Quiz coming in spring 2021, and Shaq’s Garage, starring Shaquille O’Neal for 2022. Kartoon Channel! also offers STEM-based content through its Kartoon Classroom!, including Baby Einstein, and More.

Kartoon Channel! delivers positive and purposeful content that is widely available and easily accessible across all platforms (Comcast, Cox, DISH, Sling TV, Amazon Prime, Amazon Fire, Apple TV, Android TV, Android Mobile, Google Play, Xumo, Roku, Tubi, Samsung Smart TVs, and LGTVs).

Kartoon Channel! can also be streamed on TVs and mobiles device by downloading the app, or on desktops by visiting www.kartoonchannel.com

About Genius Brands International

Genius Brands International, Inc. (Nasdaq: GNUS) is a leading global kids media company developing, producing, marketing and licensing branded children’s entertainment properties and consumer products for media and retail distribution. The Company’s ‘content with a purpose’ portfolio includes Stan Lee’s Superhero Kindergarten, starring Arnold Schwarzenegger, on Kartoon Channel!; Shaq’s Garage, starring Shaquille O’Neal on Kartoon Channel!; Rainbow Rangers on Kartoon Channel! and Netflix; Llama Llama, starring Jennifer Garner, on Netflix; award-winning toddler brand Baby Genius; adventure comedy STEM series Thomas Edison’s Secret Lab; and entrepreneurship series Warren Buffett’s Secret Millionaires Club. Through licensing agreements with leading partners, characters from Genius Brands’ IP also appear on a wide range of consumer products for the worldwide retail marketplace. The Company’s Kartoon Channel! and Kartoon Classroom! are available in over 100 million U.S. television households via a broad range of distribution platforms, including Comcast, Cox, DISH, Sling TV, Amazon Prime, Amazon Fire, Apple TV, Apple iOS, Android TV, Android Mobil, Google Play, Xumo, Roku, Tubi, YouTube, KartoonChannel.com, Samsung Smart TVs and LG TVs. For additional information, please visit www.gnusbrands.com.

Forward Looking Statements: Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation, our ability to generate revenue or achieve profitability; our ability to obtain additional financing on acceptable terms, if at all; the potential issuance of a significant number of shares, which will dilute our equity holders; fluctuations in the results of our operations from period to period; general economic and financial conditions; our ability to anticipate changes in popular culture, media and movies, fashion and technology; competitive pressure from other distributors of content and within the retail market; our reliance on and relationships with third-party production and animation studios; our ability to market and advertise our products; our reliance on third-parties to promote our products; our ability to keep pace with technological advances; our ability to protect our intellectual property and those other risk factors set forth in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K and in the Company’s subsequent filings with the Securities and Exchange Commission (the “SEC”). Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

MEDIA CONTACT:

[email protected]

INVESTOR RELATIONS CONTACT:                                                                        

[email protected]



Hoth Therapeutics Announces Development of HT-KIT to Treat Multiple Orphan Diseases, Including Rare Cancers

PR Newswire

NEW YORK, May 3, 2021 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH) a patient-focused clinical-stage biopharmaceutical company, announced it intends to pursue development of its HT-KIT mRNA Frame Shifting Therapeutic for multiple orphan diseases, which are rare diseases that affect less than 200,000 people in the US. HT-KIT targets a shared cell signaling pathway that may have therapeutic potential for multiple rare cancers, including:

  • Aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL)
  • Acute myeloid leukemia (AML)
  • Gastrointestinal stromal tumors

Drugs intended to treat orphan diseases are eligible to apply for Orphan Drug Designation (ODD), which provides multiple benefits to the sponsor during development and after approval. Hoth intends to pursue these benefits as part of the drug development for HT-KIT for treatment of rare cancers.

Benefits of Orphan Drug Designation
Under the Orphan Drug Act, drug companies can apply for ODD, and if granted, the drug will have a status which gives companies exclusive marketing and development rights along with other benefits to recover the costs of researching and developing the drug.  A tax credit of 50% of the qualified clinical drug testing costs awarded upon drug approval is also possible.   Regulatory streamlining and provide special assistance to companies that develop drugs for rare patient populations. In addition to exclusive rights and cost benefits, the FDA will provide protocol assistance, potential decreased wait-time for drug approval, discounts on registration fees, and eligibility for market exclusivity after approval.

Key benefits of ODD:

  • 7 years exclusivity post-approval
  • Tax credits of 50% off the clinical drug testing cost awarded upon approval
  • Waiver of new drug application (NDA)/ biologics license application (BLA) application fee

Hoth recently announced that its novel anti-cancer therapeutic exhibited highly positive results in humanized mast cell neoplasm models, representative in vitro and in vivo models for aggressive, mast cell-derived cancers such as mast cell leukemia and mast cell sarcoma. 

About Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. Hoth’s pipeline development is focused to improve the quality of life for patients suffering from indications including atopic dermatitis, skin toxicities associated with cancer therapy, chronic wounds, psoriasis, asthma, acne, and pneumonia. Hoth has also entered into two different agreements to further the development of two therapeutic prospects to prevent or treat COVID-19. To learn more, please visit www.hoththerapeutics.com.

Forward-Looking Statement

This press release includes forward-looking statements based upon Hoth’s current expectations which may constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995 and other federal securities laws, and are subject to substantial risks, uncertainties and assumptions. These statements concern Hoth’s business strategies; the timing of regulatory submissions; the ability to obtain and maintain regulatory approval of existing product candidates and any other product candidates we may develop, and the labeling under any approval we may obtain; the timing and costs of clinical trials, the timing and costs of other expenses; market acceptance of our products; the ultimate impact of the current Coronavirus pandemic, or any other health epidemic, on our business, our clinical trials, our research programs, healthcare systems or the global economy as a whole; our intellectual property; our reliance on third party organizations; our competitive position; our industry environment; our anticipated financial and operating results, including anticipated sources of revenues; our assumptions regarding the size of the available market, benefits of our products, product pricing, timing of product launches; management’s expectation with respect to future acquisitions; statements regarding our goals, intentions, plans and expectations, including the introduction of new products and markets; and our cash needs and financing plans. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. You should not place reliance on these forward-looking statements, which include words such as “could,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “may,” “continue,” “predict,” “potential,” “project” or similar terms, variations of such terms or the negative of those terms. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee such outcomes. Hoth may not realize its expectations, and its beliefs may not prove correct. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including, without limitation, market conditions and the factors described in the section entitled “Risk Factors” in Hoth’s most recent Annual Report on Form 10-K and Hoth’s other filings made with the U. S. Securities and Exchange Commission. All such statements speak only as of the date made. Consequently, forward-looking statements should be regarded solely as Hoth’s current plans, estimates, and beliefs. Investors should not place undue reliance on forward-looking statements. Hoth cannot guarantee future results, events, levels of activity, performance or achievements. Hoth does not undertake and specifically declines any obligation to update, republish, or revise any forward-looking statements to reflect new information, future events or circumstances or to reflect the occurrences of unanticipated events, except as may be required by applicable law.

Investor Relations Contact:

LR Advisors LLC
Email: [email protected]
www.hoththerapeutics.com  
Phone: (678) 570-6791

Media Relations Contact:
Makovsky
Miriam Brito, Assistant Vice President
Email: [email protected]
Phone: (914)-406-0435

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/hoth-therapeutics-announces-development-of-ht-kit-to-treat-multiple-orphan-diseases-including-rare-cancers-301281913.html

SOURCE Hoth Therapeutics, Inc.

SHAREHOLDER ALERT: Lowey Dannenberg, P.C., Investigates Claims on Behalf of Investors of Credit Suisse and Encourages Investors Who Lost More than $200,000 to Contact the Firm

NEW YORK, May 03, 2021 (GLOBE NEWSWIRE) — Lowey Dannenberg P.C. is investigating claims of violations of federal securities laws on behalf of investors in Credit Suisse Group AG American Depository Receipts (“ADRs”) (NYSE: CS).   If you are an investor in Credit Suisse ADRs with more than $200,000 in losses, you should contact the Firm.

The financial services giant is accused of concealing material defects in its risk policies to allow high-risk clients to take on excessive leverage, including Greensill Capital and Archegos Capital Management.  This has exposed Credit Suisse to billions of dollars in losses.  Not only did the company conceal these operational landmines from Credit Suisse investors, but they also undertook actions indicating that Credit Suisse securities were substantially undervalued, such as a massive stock buy-back program worth USD $1.6 billion.

In March 2021, Credit Suisse was required to close and liquidate several investment funds tied to the activities of Greensill Capital. The investors in the funds, which totaled assets of approximately $10 billion, lost over $3 billion. A few days later, the meltdown at Archegos, the family run business of investor Bill Hwang, unfolded as some of his biggest wagers started to move against him – positions he built with significant amounts of  money.  When Credit Suisse and other banks that had extended credit to Archegos saw Hwang’s bets turn south, they required the firm to put up more money to cover the decline. When it could not, they began to liquidate Hwang’s portfolio, with Credit Suisse sustaining billions of dollars in losses.  Following these disclosures, the ADRs lost more than $3 billion in market value.   

In April 2021, at least seven top executives were removed from their posts after Credit Suisse reported losses of $4.7 billion linked to its prime brokerage services provided to Archegos Capital.  Among others, the Company’s Chairman of the Board has resigned, the Chairman of the Board’s Risk Committee has stepped down, and the Chief Risk and Compliance Officer was terminated.

A class action lawsuit has been filed. The complaint alleges that Credit Suisse ignored numerous red flags in connection with the Greensill funds, and conspired with Bill Hwang to allow Archegos to covertly take on billions of dollars in excessively concentrated and risky positions that injured Credit Suisse and its investors. If you purchased or otherwise acquired Credit Suisse ADRs between October 29, 2020 and March 31, 2021, and wish to participate, learn more, or discuss the issues surrounding the investigation, please contact our attorneys at (914) 733-7228 or (914) 733-7226, or via email at [email protected].   If you suffered a loss in Credit Suisse ADRs you have until June 15, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Whistleblowers: Persons with non-public information regarding RIDE should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.

Contact

Lowey Dannenberg P.C.
44 South Broadway, Suite 1100 
White Plains, NY 10601
Tel: (914) 733-7228 or (914) 733-7226
Email: [email protected]



Bristol Myers Squibb Presents New Clinical and Real-World Data on Mavacamten and Obstructive Hypertrophic Cardiomyopathy at Upcoming American College of Cardiology’s 70th Annual Scientific Session

Bristol Myers Squibb Presents New Clinical and Real-World Data on Mavacamten and Obstructive Hypertrophic Cardiomyopathy at Upcoming American College of Cardiology’s 70th Annual Scientific Session

New analysis of EXPLORER-HCM trial assessing impact of mavacamten on patient’s health status to be presented as late-breaking oral presentation

Interim results of EXPLORER long-term extension study of mavacamten safety and efficacy data in patients with obstructive hypertrophic cardiomyopathy (oHCM) also to be presented

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that data from multiple studies across the company’s clinical program investigating mavacamten in patients with obstructive hypertrophic cardiomyopathy (oHCM) will be presented at the upcoming American College of Cardiology’s 70th Annual Scientific Session (ACC.21), being held virtually May 15 to May 17, 2021.

Key presentations include:

  • A late-breaking oral presentation reporting results from a new analysis of data from the EXPLORER-HCM Phase 3 trial of mavacamten in patients with oHCM, which tested the impact of mavacamten on patients’ health status (symptoms, function and quality of life) as measured by the Kansas City Cardiomyopathy Questionnaire. These data will be presented as part of the Featured Clinical Research I Session in the Hot Topics Channel on Saturday, May 15 from 12:15 – 1:30 p.m. EDT.
  • A moderated poster session highlighting interim results from MAVA-LTE, an ongoing, dose-blinded 5-year extension study of the EXPLORER-HCM Phase 3 trial. Findings from the interim analysis demonstrated that in patients with oHCM, mavacamten was well tolerated and showed durable improvement in left ventricular outflow tract (LVOT) gradients, diastolic function, N-terminal-pro hormone B-type natriuretic peptide (NT-proBNP) and symptoms.
  • A poster presentation of results from a real-world data analysis measuring the clinical and economic burden of oHCM in the United States, which found the condition is associated with substantial healthcare resource utilization and costs.

“These data add to the growing body of evidence that further supports the goal of addressing a high unmet medical need in patients with oHCM with mavacamten as a first-in-class medicine,” said Jay Edelberg, M.D., Ph.D., head, Heart Failure and Cardiomyopathy Development at Bristol Myers Squibb. “We look forward to potentially bringing this therapy to oHCM patients early next year.”

Mavacamten Presentations

  • Health Status Benefits of Mavacamten in Patients with Symptomatic Obstructive Cardiomyopathy: Results From the EXPLORER-HCM Randomized Clinical Trial

    • Author: John A. Spertus
    • Session 403-09 – Featured Clinical Research I
    • Session Type: Late-Breaking Clinical Trials, Hot Topics Channel
    • Saturday, May 15: 12:15 – 12:25 p.m. EDT
  • Long-Term Safety of Mavacamten in Patients with Obstructive Hypertrophic Cardiomyopathy: Interim Results of the MAVA-Long Term Extension (LTE) Story

    • Author: Florian Rader
    • Session 1033-03 – Advances in Hypertrophic Cardiomyopathy
    • Session Type: Moderated Poster Contributions, eAbstract Site
    • Saturday, May 15: 12:30 – 12:40 p.m. EDT
  • Clinical and Economic Burden of Obstructive Hypertrophic Cardiomyopathy in the United States

    • Author: Sneha S. Jain
    • Session 2192 – Heart Failure and Cardiomyopathies: Population Science 1
    • Session Type: Poster Contributions, eAbstract Site
    • Saturday, May 15: 2:45 – 3:30 p.m. EDT

About Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is a chronic, progressive disease in which excessive contraction of the heart muscle and reduced ability of the left ventricle to fill can lead to the development of debilitating symptoms and cardiac dysfunction. HCM is estimated to affect one in every 500 people.

The most frequent cause of HCM is mutations in the heart muscle proteins of the sarcomere. In either obstructive or non-obstructive HCM patients, exertion can result in fatigue or shortness of breath, interfering with a patient’s ability to participate in activities of daily living. HCM has also been associated with increased risks of atrial fibrillation, stroke, heart failure and sudden cardiac death, with mortality among HCM patients shown to be approximately three-fold higher than the U.S. general population at similar ages.

There are currently approximately 160,000 to 200,000 people diagnosed with symptomatic obstructive HCM across the U.S. and EU, with no existing effective drug treatment options beyond limited symptomatic relief.

About Mavacamten

Mavacamten is a potential first-in-class, oral, allosteric modulator of cardiac myosin, under investigation for the treatment of conditions in which excessive cardiac contractility and impaired diastolic filling of the heart are the underlying cause. Mavacamten reduces cardiac muscle contractility by inhibiting excessive myosin-actin cross-bridge formation that results in hypercontractility, left ventricular hypertrophy and reduced compliance. In clinical and preclinical studies, mavacamten has consistently reduced biomarkers of cardiac wall stress, lessened excessive cardiac contractility and increased diastolic compliance.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook and Instagram.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things, the research, development and commercialization of pharmaceutical products. All statements that are not statements of historical facts are, or may be deemed to be, forward-looking statements. Such forward-looking statements are based on historical performance and current expectations and projections about our future financial results, goals, plans and objectives and involve inherent risks, assumptions and uncertainties, including internal or external factors that could delay, divert or change any of them in the next several years, that are difficult to predict, may be beyond our control and could cause our future financial results, goals, plans and objectives to differ materially from those expressed in, or implied by, the statements. These risks, assumptions, uncertainties and other factors include, among others, the possibility that future study results will be consistent with the results to date, that mavacamten may not receive regulatory approval for the indication(s) described in this release in the currently anticipated timeline or at all and, if approved, whether such product candidate for such indication(s) described in this release will be commercially successful. No forward-looking statement can be guaranteed. Forward-looking statements in this press release should be evaluated together with the many risks and uncertainties that affect Bristol Myers Squibb’s business and market, particularly those identified in the cautionary statement and risk factors discussion in Bristol Myers Squibb’s Annual Report on Form 10-K for the year ended December 31, 2020, as updated by our subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings with the Securities and Exchange Commission. The forward-looking statements included in this document are made only as of the date of this document and except as otherwise required by applicable law, Bristol Myers Squibb undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise.

corporatefinancial-news

Bristol Myers Squibb

Media Inquiries:

[email protected]

Susan Francis

[email protected]

609-529-0676

Investors:

Tim Power

[email protected]

609-252-7509

KEYWORDS: United States North America New Jersey

INDUSTRY KEYWORDS: Research Clinical Trials Cardiology Other Health Biotechnology General Health Pharmaceutical Health Science Other Science

MEDIA:

Logo
Logo